share_log

中國石墨：截至2023年12月31日止月份之股份發行人的證券變動月報表

CHINA GRAPHITE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

香港交易所 ·  Jan 3 03:48
Summary by Moomoo AI
中国石墨於2024年1月3日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本及已發行股份在該月份均無變動，維持在2,000,000,000股，每股面值0.001港元，總額2,000,000港元。此外，公司於2022年6月21日採納的股份期權計劃下，本月底結存的股份期權數目為160,000,000股，但本月內無新增發行股份。執行董事李偉海確認，所有證券發行均已獲董事會授權，並符合相關法律規定。
中国石墨於2024年1月3日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本及已發行股份在該月份均無變動，維持在2,000,000,000股，每股面值0.001港元，總額2,000,000港元。此外，公司於2022年6月21日採納的股份期權計劃下，本月底結存的股份期權數目為160,000,000股，但本月內無新增發行股份。執行董事李偉海確認，所有證券發行均已獲董事會授權，並符合相關法律規定。
China Graphite filed with Hong Kong Trading and Clearing Limited on 3 January 2024 the Monthly Securities Change Report for the year ended 31 December 2023. The report shows that the company's regulated/registered share capital and issued shares remained unchanged during the month at 2,000,000,000 shares with a face value of HK$0.001 per share for a total of HK$2,000,000. In addition, under the Company's stock option plan adopted on June 21, 2022, the number of outstanding stock options at the end of the month was 160,000,000 shares, but no new shares were issued during the month. Executive Director Li Weihai confirms that all securities issuance has been authorized by the Board of Directors and in compliance with relevant legal requirements.
China Graphite filed with Hong Kong Trading and Clearing Limited on 3 January 2024 the Monthly Securities Change Report for the year ended 31 December 2023. The report shows that the company's regulated/registered share capital and issued shares remained unchanged during the month at 2,000,000,000 shares with a face value of HK$0.001 per share for a total of HK$2,000,000. In addition, under the Company's stock option plan adopted on June 21, 2022, the number of outstanding stock options at the end of the month was 160,000,000 shares, but no new shares were issued during the month. Executive Director Li Weihai confirms that all securities issuance has been authorized by the Board of Directors and in compliance with relevant legal requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more